REQUEST A DEMO
Total
USD $0.00
Search more companies

Farmacija 2011 Bihac d.o.o. (Bosnia and Herzegovina)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Farmacija 2011 Bihac d.o.o. Profile Updated: October 09, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Farmacija 2011 Bihac is a pharmaceutical company that specializes in the distribution of medicines and medical resources. They focus on building partnerships with suppliers and customers through open cooperation and trust. Farmacija 2011 Bihac operates its own storage capacity for finished medications and medical devices and has become one of the pharmaceutical carrier companies in Bosnia and Herzegovina. They consolidate clinical centers, hospitals, health houses, and pharmacies in the area of BiH. The company has received the Resolution of Medicines and Medical Resources Agency of BiH for carrying out pharmaceutical transport activities.

Headquarters
Zagrebachka 2. Str.
Bihac; Una-Sana; Postal Code: 77000

Contact Details: Purchase the Farmacija 2011 Bihac d.o.o. report to view the information.

Website: https://farmacija2011.ba

Basic Information
Total Employees:
Purchase the Farmacija 2011 Bihac d.o.o. report to view the information.
Outstanding Shares:
Purchase the Farmacija 2011 Bihac d.o.o. report to view the information.
Incorporation Date:
2011
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Farmacija 2011 Bihac d.o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Total operating revenue
14.34%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?